About Tecentriq SC 1875 mg Injection
Capitalise on the new release of Tecentriq SC 1875 mg Injection, a flawless immunotherapy designed for adult patients with qualifying cancer types. Take advantage of its enviable precision-a kingly option for oncology, this single-use, pre-filled syringe ensures high accuracy in each subcutaneous dose, preferably administered in the thigh. Free from antimicrobial preservatives and safeguarded by sterile glass packaging, Tecentriq SC provides a ready-to-use, clear solution stored refrigerated. Trusted globally, it must be administered by professionals and is for hospital use only.
Enviable Features and Diverse Applications
Tecentriq SC 1875 mg Injection sets itself apart with its kingly subcutaneous delivery, eliminating preparation complexity with a ready-to-use formulation and precision dosing. This flawless injection is ideal for various cancers, including non-small cell lung cancer, small cell lung cancer, and triple-negative breast cancer. Its biotechnological manufacturing ensures an isotonic, odorless, and clear to slightly yellow solution, with no enzymatic activity or preservatives, making it a dependable option for hospitals and oncology specialists alike.
Efficient Delivery, Secure Payment, and Sample Options
Logistics for Tecentriq SC 1875 mg Injection are streamlined to ensure prompt goods transport, with stock ready for quick dispatch. Delivery times depend on your location and preferred logistics partner, guaranteeing timely arrival of your product. Payment terms are flexible to suit institutional and wholesale requirements. Sample availability upon request provides assurance in quality and compatibility prior to bulk procurement, making this solution ideal for hospital supply chains and pharmaceutical distributors.
FAQ's of Tecentriq SC 1875 mg Injection:
Q: How should Tecentriq SC 1875 mg Injection be administered for optimal results?
A: Tecentriq SC 1875 mg Injection should be administered subcutaneously, preferably in the thigh, by a qualified healthcare professional in a hospital setting to ensure precise dosing and safety.
Q: What cancers is Tecentriq SC 1875 mg Injection indicated for?
A: Tecentriq SC is indicated for various cancers, notably non-small cell lung cancer, small cell lung cancer, and triple-negative breast cancer, among other eligible malignancies that respond to immunotherapy.
Q: When should Tecentriq SC 1875 mg Injection not be used?
A: Tecentriq SC should not be used in patients with known hypersensitivity to atezolizumab or its excipients. It is prescription-only, and professional medical guidance is essential prior to initiation.
Q: Where should Tecentriq SC 1875 mg Injection be stored?
A: This injection must be stored in a refrigerator at 2C to 8C. It should not be frozen and must be protected from light to maintain stability and effectiveness.
Q: What is the process for ordering Tecentriq SC for hospital use?
A: Hospitals and authorized institutions can place orders through licensed exporters, suppliers, traders, or wholesalers. Delivery is coordinated with stock readiness and efficient logistics, with payment terms tailored as per contractual agreements.
Q: How does using Tecentriq SC benefit oncology treatment protocols?
A: Tecentriq SC enables immunotherapy via a monoclonal antibody that offers high-precision, ready-to-use dosing, supporting hospitals in delivering advanced care to eligible cancer patients.